Search Results - "Shah‐Hosseini, K."

Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B‐cell response in seasonal allergic rhinitis patients by Mösges, R., Koch, A. F., Raskopf, E., Singh, J., Shah‐Hosseini, K., Astvatsatourov, A., Hauswald, B., Yarin, Y., Corazza, F., Haazen, L., Pirotton, S., Allekotte, S., Zadoyan, G., Legon, T., Durham, S. R., Shamji, M. H.

“…Background Systemic allergic reactions are a risk for allergen immunotherapy that utilizes intact allergen preparations. We evaluated the safety, efficacy and…”
Get full text

Ultra‐short‐course booster is effective in recurrent grass pollen‐induced allergic rhinoconjunctivitis by Pfaar, O., Lang, S., Pieper‐Fürst, U., Astvatsatourov, A., Gerich, F., Klimek, L., Kramer, M. F., Reydelet, Y., Shah‐Hosseini, K., Mösges, R.

“…Background A relevant proportion of allergic rhinoconjunctivitis (ARC) patients experience recurrent symptoms after successfully completing allergen…”
Get full text

A randomized, double‐blind, placebo‐controlled, dose‐finding trial with Lolium perenne peptide immunotherapy by Mösges, R., Kasche, E. M., Raskopf, E., Singh, J., Sohlich, L., Astvatsatourov, A., Shah‐Hosseini, K., Pirotton, S., Haazen, L., Durham, S. R., Legon, T., Zadoyan, G., Shamji, M. H.

“…Background A novel subcutaneous allergen immunotherapy formulation (gpASIT+™) containing Lolium perenne peptides (LPP) and having a short up‐dosing phase has…”
Get full text

RCAT reflects symptom control and quality of life in allergic rhinoconjunctivitis patients by Liedtke, J.‐P., Mandl, A., Köther, J., Chwieralski, J., Shah‐Hosseini, K., Raskopf, E., Pieper‐Fürst, U., Allekotte, S., Mösges, R.

“…Background The Global Allergy and Asthma European Network (GA2LEN) Taskforce has requested more data on correlations between various patient‐reported outcomes…”
Get full text

A 12‐week DBPC dose‐finding study with sublingual monomeric allergoid tablets in house dust mite‐allergic patients by Hüser, C., Dieterich, P., Singh, J., Shah‐Hosseini, K., Allekotte, S., Lehmacher, W., Compalati, E., Mösges, R.

“…Background In sublingual immunotherapy, optimal doses are a key factor for therapeutic outcomes. The aim of this study with tablets containing carbamylated…”
Get full text

Medication persistence with long-term, specific grass pollen immunotherapy measured by prescription renewal rates by Sieber, J., De Geest, S., Shah-Hosseini, K., Mösges, R.

“…Abstract Objective: We assessed medication persistence using prescription renewal rates for grass pollen specific immunotherapy (SIT) in a representative…”
Get full text

Objectifying the conjunctival provocation test: photography-based rating and digital analysis by Dogan, S, Astvatsatourov, A, Deserno, T M, Bock, F, Shah-Hosseini, K, Michels, A, Mösges, R

“…Patients with allergic rhinoconjunctivitis are susceptible to both nasal and ocular symptoms. The conjunctival provocation test (CPT) is an established…”
Get more information

Success factors for adherence in hyposensitization by Sondermann, N, Shah-Hosseini, K, Henkel, K, Schwalfenberg, A, Mösges, R

“…For the success of an immunotherapy regimen, adherence is a major success factor. The goal of our study was to identify the factors that positively and…”
Get full text

Efficacy and tolerability of bromelain in patients with chronic rhinosinusitis--a pilot study by Büttner, L, Achilles, N, Böhm, M, Shah-Hosseini, K, Mösges, R

“…To evaluate the efficacy, tolerability, and impact on quality of life (QoL) of bromelain tablets (500 FIP) in patients with chronic rhinosinusitis (CRS). In…”
Get more information

A meta-analysis of the efficacy of quinolone containing otics in comparison to antibiotic-steroid combination drugs in the local treatment of otitis externa by Mösges, R., Nematian-Samani, M., Hellmich, M., Shah-Hosseini, K.

“…Abstract Background: The term otitis externa denotes the inflammation of the external auditory canal and can be treated locally in the form of monotherapy or a…”
Get full text

4-Phase-Rhinomanometry (4PR)--basics and practice 2010 by Vogt, Klaus, Jalowayski, Alfredo A, Althaus, W, Cao, C, Han, D, Hasse, W, Hoffrichter, H, Mösges, R, Pallanch, J, Shah-Hosseini, K, Peksis, K, Wernecke, K D, Zhang, L, Zaporoshenko, P

“…The last comprehensive publications about the theory and practice of rhinomanometry appeared more than 20 years ago. Since the 1980's, the general progress of…”
Get more information

Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy center by Lemberg, Marie-Luise, Berk, Till, Shah-Hosseini, Kija, Kasche, Elena-Manja, Mösges, Ralph

“…Many placebo-controlled studies have demonstrated that allergen immunotherapy (AIT) is an effective therapy for treating allergies. Both commonly used routes,…”
Get full text

Skin prick test evaluation of Dermatophagoides pteronyssinus diagnostic extracts from Europe, Mexico, and the United States by Larenas-Linnemann, Désirée, MD, Matta, Juan José, MD, Shah-Hosseini, Kijawasch, Dipl.-Biol.Dr, Michels, Alexandra, Cand. Med. Dipl.-Sportwiss, Mösges, Ralph, Dr. Med. Dipl.-Ing

“…Background Previous Food and Drug Administration (FDA)–approved enzyme-linked immunosorbent assay testing of Dermatophagoides pteronyssinus diagnostic extracts…”
Get full text

Haut und Schleimhäute by Weber, F. C., Esser, P., Müller, T., Ganesan, J., Pellegatti, P., Simon, M., Zeiser, R., Idzko, M., Jakob, T., Martin, S., Mitzel-Kaoukhov, H., Groffik, A., Goloborodko, E., Saloga, J., Staubach, P., Loth, C., Hengst, M., Ott, H., Lau, K., Klein, J., Höger, P., Bohnsack, K., Fiege, A., Dickschat, U., Filbry, A., Rippke, F., Fölster-Holst, R., Weißmantel, S., Galecka, J., Werfel, T., Wichmann, K., Schwarz, T., Vogt, A., Lademann, J., Meinke, M. C., Rödiger, C., Tittelbach, J., Schliemann, S., Elsner, P., Hipler, U.-C., Jung, A. G., Hippe, S., Zouboulis, C., Lippert, U., Hessam, S., Altmeyer, P., Dickel, H., Buchner, M., Gläser, R., Gerstel, U., Mahsur, C., Matthiessen, A., Sahin, G., Pfaar, O., Klimek, L., Nematian-Samani, M., Mösges, R., Hellmich, M., Shah-Hosseini, K.

Get full text